Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
[Collagen N-Telopeptide Excretion in Men: The Effects of Age and Intrasubject Variability]
Journal of Clinical Endocrinology and Metabolism, 83(11):3935-3935
Lectura recomendada:
[Risk Factors for the Development of Vertebral and Total Skeleton Osteoporosis in Patients with Primary Biliary Cirrhosis]
Calcified Tissue International, 63:390-390
Lectura recomendada:
[Is Parathyroid Hormone a Therapeutic Option for Osteoporosis? A Review of the Clinical Evidence.
Calcified Tissue International, 62:480-480
Lectura recomendada:
[Bone Mineral Density and Bone Turnover in Asthmatics Treated with Long Term Inhaled or Oral Glucocorticoids]
Journal of Bone and Mineral Research, 13(8):1289-1289
Lectura recomendada:
[Effects of Lithium Therapy on Bone Mineral Metabolism: A Two-Year Prospective Longitudinal Study]
Journal of Clinical Endocrinology and Metabolism, 83(11):3859-3859
Lectura recomendada:
[Comparison of fine-needle aspiration cytologic findings of ovarian cysts with ovarian histologic findings]
American Journal of Obstetrics and Gynecology, 180(3):553-553
Lectura recomendada:
[The Effect of Low Dose Continuous Estrogen and Progesterone Therapy with Calcium and Vitamin D on Bone in Elderly Women]
Annals of Internal Medicine, 130:904-904
Lectura recomendada:
[Selective estrogen receptor modulators: Women's panacea for the next millennium?]
American Journal of Obstetrics and Gynecology, 180(3):770-770
Lectura recomendada:
Epidemiology Branch and Biostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, NC, EE.UU.
American Journal of Obstetrics and Gynecology, 180(3):581-586
Lectura recomendada:
[Double-Blind Comparison of Carbetocin versus Oxytocin in Prevention of Uterine Atony after Cesarean Section]
American Journal of Obstetrics and Gynecology, 180(3):676-676
Lectura recomendada:
[Posoperative radiotherapy in high risk posmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial]
The Lancet, 353:1648-1648